LEADER 03191nam  22006012  450 
001 9910454132103321
005 20160512105003.0
010   $a1-107-19285-4
010   $a0-511-51773-4
010   $a0-511-51511-1
010   $a0-511-51419-0
010   $a0-511-57552-1
010   $a0-511-51639-8
035   $a(CKB)1000000000748430
035   $a(EBL)431984
035   $a(OCoLC)609832748
035   $a(SSID)ssj0000113427
035   $a(PQKBManifestationID)11140386
035   $a(PQKBTitleCode)TC0000113427
035   $a(PQKBWorkID)10099258
035   $a(PQKB)10778432
035   $a(UkCbUP)CR9780511575525
035   $a(MiAaPQ)EBC431984
035   $a(Au-PeEL)EBL431984
035   $a(CaPaEBR)ebr10297129
035   $a(EXLCZ)991000000000748430
100   $a20141103d2009||||  uy|            0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 14$aThe BMT data book /$fReinhold Munker, Hillard M. Lazarus, Kerry Atkinson$b[electronic resource]
205   $a2nd edition.
210  1$aCambridge :$cCambridge University Press,$d2009.
215   $a1 online resource (xvi, 526 pages) $cdigital, PDF file(s)
300   $aTitle from publisher's bibliographic system (viewed on 05 Oct 2015).
311   $a0-521-71100-2 
320   $aIncludes bibliographical references and index.
327   $aCover; Half-title; Title; Copyright; Contents; Contributors; Foreword; Preface; Acknowledgments; Section 1 Basic science; Section 2 Hematologic malignancies; Section 3 Solid tumors; Section 4 Nonmalignant disorders; Section 5 Practical aspects and procedures; Section 6 Complications; Section 7 The BMT/SCT pharmacopoeia; Section 8 HLA-testing and laboratorymedicine; Appendix; Index
330   $aThe BMT Data Book is an essential guide to the data, outcome studies and complex decision-making processes involved in blood and marrow stem cell transplantation. Organized according to types of diseases and procedures, it contains more than hundred tables, figures and algorithms that reflect up-to-date research and give guidance on the choices between stem cell versus bone marrow transplantation, autologous versus allogeneic transplantation, and conventional versus experimental treatments.  This new edition summarizes research of the last 5 years and gives mature data for all established indications, such as acute myeloid leukemia, myelodysplastic syndromes, Hodgkin's and Non-Hodgkin's lymphomas. In addition, controversies and new indications - like renal cell cancer and autoimmune disorders - are discussed plus new drugs and therapies, new stem cell sources (cord blood), new transplant protocols (reduced-intensity conditioning), and a guide to electronic databases.
606   $aBone marrow$xTransplantation
615  0$aBone marrow$xTransplantation.
676   $a617.4/40592
700   $aAtkinson$b Kerry$01046442
702   $aMunker$b Reinhold
702   $aLazarus$b Hillard M.
801  0$bUkCbUP
801  1$bUkCbUP
906   $aBOOK
912   $a9910454132103321
996   $aThe BMT data book$92473333
997   $aUNINA